Skip to yearly menu bar Skip to main content


Poster
in
Workshop: New Frontiers of AI for Drug Discovery and Development

Leap: molecular synthesisability scoring with intermediates

Antonia Calvi · Théophile Gaudin · Dominik Miketa · Dominique Sydow · Liam Wilbraham

Keywords: [ transformers ] [ GPT2 ] [ molecular synthesisability ] [ molecular scorer ]


Abstract:

Assessing whether a molecule can be synthesised is a primary task in drug discovery. It enables computational chemists to filter for viable compoundsor bias molecular generative models. The notion of synthesisability is dynamic as it evolves depending on the availability of key compounds. A common approach in drug discovery involves exploring the chemical space surrounding synthetically-accessibleintermediates. This strategy improves the synthesisability of the derived molecules due to the availability of key intermediates.Existing synthesisability scoring methods such as SAScore, SCScore and RAScore, cannot condition on intermediates dynamically.Our approach, Leap, is a GPT-2 model trained on the depth, or longest linear path, of predicted synthesis routes that allows information on the availability of key intermediates to be included at inference time.We show that Leap surpasses all other scoring methods by at least 5% on AUC score when identifying synthesisable molecules, and can successfully adapt predicted scores when presented with a relevant intermediate compound.

Chat is not available.